EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines.By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before.The company was founded in 2019 and is based in Cambridge, Massachusetts, United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 17, 2021 | Post-IPO Equity | $1.20B | 2 | SB Life Science | — | Detail |
Jan 11, 2021 | Series B | $500M | 1 | — | — | Detail |
Jan 12, 2020 | Series A | $200M | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 15, 2021
Bit.Country Network
|
Seed | $4M | Blockchain | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SB Life Science | Yes | Post-IPO Equity |
Verily | — | Post-IPO Equity |
ARCH Venture Partners | — | Series B |